Adial Pharmaceuticals agrees to merge with Azora Therapeutics
Adial Pharmaceuticals signed a merger agreement with Azora Therapeutics, effective June 11, 2026, combining the two pharmaceutical companies. The transaction involves a two-step merger structure with detailed terms for share conversion and consideration exchange.
View filing at SEC.gov →